Apr 8, 2015
Allergy drug inhibits hepatitis C in mice
An over-the-counter drug indicated to treat allergy symptoms limited hepatitis C virus activity in infected mice, according to a National Institutes of Health study.
Provides information on the latest Network of Minority Health Research Investigators’ workshop, member collaborations, awards, news from the oversight committee and more.
NIH Nutrition Quarterly
Features updates on the NIH nutrition research community and share some of the exciting activities taking place. From training opportunities to novel research findings, the NIH Nutrition Quarterly will highlight significant nutrition happenings at NIH.
NKDEP Nutrition News for Dietitians
Provides registered dietitians and nutritionists interested in chronic kidney disease updates on new NKDEP diet-related materials and activities, as well as opportunities to assist NKDEP and its efforts.
Dec 4, 2014
NIH study finds genetic links between common kidney and digestive diseases
NIH-supported researchers have found six new regions in the human genome that increase susceptibility to immunoglobulin A nephropathy (IgAN), a major cause of kidney failure worldwide. The susceptibility genes are found in people of Asian and European ancestries and affect the risk of developing IgAN and the age at which disease develops.
Nov 17, 2014
Two drugs are no more effective than one to treat common kidney disease
Using two drugs was no more effective than a single drug in slowing disease progression in people with autosomal dominant polycystic kidney disease (ADPKD), according to two studies funded by the National Institutes of Health (NIH). One of the studies also showed that rigorous blood pressure treatment slowed growth of kidney cysts, a marker of ADPKD, but had little effect on kidney function compared to standard blood pressure treatment.
Nov 7, 2014
New drug for common liver disease improves liver health
An experimental drug aimed at treating a common liver disease showed promising results and potential problems in a multicenter clinical trial funded by the National Institutes of Health. The FLINT study found that people with nonalcoholic steatohepatitis (NASH) who took obeticholic acid (OCA) had improved liver health during that period, including decreased inflammation and fat in the liver and decreased body weight versus people receiving a placebo. OCA was also associated with increases in itching and total cholesterol.
Nov 3, 2014
This National Diabetes Month, take steps to improve diabetes outcomes
More than 29 million Americans have diabetes, and about 86 million more are on the verge of the disease. People with diabetes are nearly two times more likely than people without diabetes to die from heart disease, and are also at greater risk for kidney, eye and nerve diseases, among other painful and costly complications.
Oct 9, 2014
NIH invests almost $32 million to increase utility of biomedical research data
Wide-ranging National Institutes of Health grants announced today will develop new strategies to analyze and leverage the explosion of increasingly complex biomedical data sets, often referred to as Big Data. These NIH multi-institute awards constitute an initial investment of nearly $32 million in fiscal year 2014 by NIH's Big Data to Knowledge (BD2K) initiative.
Sep 9, 2014
Eating habits, body fat related to differences in brain chemistry
People who are obese may be more susceptible to environmental food cues than their lean counterparts due to differences in brain chemistry that make eating more habitual and less rewarding, according to a National Institutes of Health study published in Molecular Psychiatry.
Aug 1, 2014
Spectrum of statin hepatotoxicity: Experience of the drug-induced liver injury network
The HMG-CoA reductase inhibitors (statins) are widely prescribed for patients with hyperlipidemia and are generally well tolerated. Mild elevations in serum aminotransferases arise in up to 3% of treated patients, but clinically apparent drug-induced liver injury is rare. The aim of this study is to report the presenting features and outcomes of 22 patients with clinically apparent liver injury due to statins.